BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22749243)

  • 1. Occurrence and molecular characterization of Klebsiella pneumoniae ST37 clinical isolates producing plasmid-mediated AmpC recovered over a 3-year period.
    Illiaquer M; Caroff N; Bémer P; Aubin GG; Juvin ME; Lepelletier D; Reynaud A; Corvec S
    Diagn Microbiol Infect Dis; 2012 Sep; 74(1):95-7. PubMed ID: 22749243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
    Pai H; Seo MR; Choi TY
    Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of carbapenem resistance among plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae during outbreaks in liver transplantation units.
    Matsumura Y; Tanaka M; Yamamoto M; Nagao M; Machida K; Ito Y; Takakura S; Ogawa K; Yoshizawa A; Fujimoto Y; Okamoto S; Uemoto S; Ichiyama S
    Int J Antimicrob Agents; 2015 Jan; 45(1):33-40. PubMed ID: 25455850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand.
    Singtohin S; Chanawong A; Lulitanond A; Sribenjalux P; Auncharoen A; Kaewkes W; Songsri J; Pienthaweechai K
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):271-7. PubMed ID: 20851550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.
    Kang CI; Pai H; Kim SH; Kim HB; Kim EC; Oh MD; Choe KW
    J Antimicrob Chemother; 2004 Dec; 54(6):1130-3. PubMed ID: 15486080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
    Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
    Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit.
    Bagattini M; Crivaro V; Di Popolo A; Gentile F; Scarcella A; Triassi M; Villari P; Zarrilli R
    J Antimicrob Chemother; 2006 May; 57(5):979-82. PubMed ID: 16531430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients.
    Ohana S; Leflon V; Ronco E; Rottman M; Guillemot D; Lortat-Jacob S; Denys P; Loubert G; Nicolas-Chanoine MH; Gaillard JL; Lawrence C
    Antimicrob Agents Chemother; 2005 May; 49(5):2095-7. PubMed ID: 15855536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China.
    Qi Y; Wei Z; Ji S; Du X; Shen P; Yu Y
    J Antimicrob Chemother; 2011 Feb; 66(2):307-12. PubMed ID: 21131324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
    Leavitt A; Navon-Venezia S; Chmelnitsky I; Schwaber MJ; Carmeli Y
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3026-9. PubMed ID: 17562800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring bla(KPC) from New York City and Toronto.
    Mataseje LF; Boyd DA; Willey BM; Prayitno N; Kreiswirth N; Gelosia A; Poutanen SM; Low DE; Jenkins SG; Katz K; Mulvey MR
    J Antimicrob Chemother; 2011 Jun; 66(6):1273-7. PubMed ID: 21406433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
    Conejo MC; Hernández JR; Pascual A
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
    Wang Y; Li ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.
    Song W; Lee KM; Kim HS; Kim JS; Kim J; Jeong SH; Roh KH
    Int J Antimicrob Agents; 2006 Dec; 28(6):520-4. PubMed ID: 17095195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and molecular characterisation of plasmidic AmpC beta-lactamases in Klebsiella pneumoniae isolates from a tertiary-care hospital in Dublin, Ireland.
    Roche C; Boo TW; Walsh F; Crowley B
    Clin Microbiol Infect; 2008 Jun; 14(6):616-8. PubMed ID: 18397332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
    Bidet P; Burghoffer B; Gautier V; Brahimi N; Mariani-Kurkdjian P; El-Ghoneimi A; Bingen E; Arlet G
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3562-5. PubMed ID: 16048985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.
    Leavitt A; Chmelnitsky I; Ofek I; Carmeli Y; Navon-Venezia S
    J Antimicrob Chemother; 2010 Feb; 65(2):243-8. PubMed ID: 19939824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.
    Villegas MV; Lolans K; Correa A; Suarez CJ; Lopez JA; Vallejo M; Quinn JP;
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2880-2. PubMed ID: 16870793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae.
    Lee K; Hong SG; Park YJ; Lee HS; Song W; Jeong J; Yong D; Chong Y
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.